Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Organic Chemistry >  Organometalate >  OXONIC ACID POTASSIUM SALT

OXONIC ACID POTASSIUM SALT

Basic information Safety Supplier Related

OXONIC ACID POTASSIUM SALT Basic information

Product Name:
OXONIC ACID POTASSIUM SALT
Synonyms:
  • 1,4,5,6-tetrahydro-4,6-dioxo-s-triazine-2-carboxylicacid,potassiumsalt
  • 5-azaoroticacid,potassiumsalt
  • 4,6-Dihydroxy-1,3,5-triazine-2-carboxylic acid potassium salt, Allantoxanic acid
  • (OXO)Oteracil potassium
  • Potassium 4,6-dioxo-1H-1,3,5-triazine-2-carboxylate
  • Potassium s-triazine-2,4-dione-6-carboxylate
  • 1,4,5,6-Tetrahydro-4,6-dioxo-1,3,5-triazine-2-carboxylic acid potassium salt
  • Allantoxanic acid potassium
CAS:
2207-75-2
MF:
C4H2KN3O4
MW:
195.17
EINECS:
218-627-5
Product Categories:
  • Anti-cancer&immunity
  • oncology
  • Classes of Metal Compounds
  • K (Potassium) Compounds (excluding simple potassium salts)
  • Typical Metal Compounds
  • Heterocycles
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
  • Anticancer
Mol File:
2207-75-2.mol
More
Less

OXONIC ACID POTASSIUM SALT Chemical Properties

Melting point:
300 °C(lit.)
storage temp. 
Inert atmosphere,2-8°C
solubility 
Aqueous Base (Slightly), Water (Slightly, Heated, Sonicated)
form 
Powder
color 
White
biological source
rabbit
Water Solubility 
Soluble in hot water.
CAS DataBase Reference
2207-75-2(CAS DataBase Reference)
More
Less

Safety Information

Safety Statements 
24/25
WGK Germany 
3
RTECS 
RR4580000
HS Code 
29349990

MSDS

More
Less

OXONIC ACID POTASSIUM SALT Usage And Synthesis

Description

Oxonic acid is a uricase inhibitor that prevents metabolism and excretion of uric acid and induces embryotoxicity and nephrotoxicity in rats. It is a component of S-1, a mixture containing a prodrug of the antitumor agent 5-fluorouracil (5-FU; ), that suppresses the gastrointestinal toxicity of 5-FU without inhibiting its antitumor activity in rats. Formulations containing oxonic acid have been used to treat gastric, pancreatic, lung, head, neck, and breast carcinomas.

Chemical Properties

Off-White Solid

Uses

Antitumor effect potentiator and antitumor agent

Uses

Oxonic acid potassium salt is an inhibitor of uricase. The product from Sigma has been used for the inhibition of 5-fluorouracil-induced gastrointestinal toxicity without the loss of its antitumor activity in rats. It has also been used to induce hyperuricemia in rats; as it inhibits uric acid metabolism.

Definition

ChEBI: Potassium 2,6-dihydroxytriazinecarboxylate is an organic molecular entity.

in vivo

Potassium oxonate can be used in animal modeling to create hyperuricemia models. After metabolism, Potassium oxonate primarily distributes within the cells of the small intestine. In the gastrointestinal tract, Potassium oxonate is converted to cyanuric acid via two pathways: the first involves direct conversion by gut microbiota in the cecum, and the second involves conversion through xanthine oxidase, or after degradation by stomach acid into 5-aza-uracil (5-AZU), followed by conversion through aldehyde oxidase[3].

Induction of High Uric Acid[4]
Background
Potassium oxonate is a selective competitive uricase inhibitor that blocks the action of hepatic uricase.
Specific Modeling Methods
Mice : Kunming ? male ? 18-22 g
Administration: 300 mg/kg ? i.p. ? once daily for 14 days
Note
(1) The animals are adapted to the environment for 1 week before the experiment. All animals have access to a standard diet and water ad libitum and are acclimated to specific pathogen-free (SPF) conditions of 22 ± 2 °C, 60 ± 5% humidity, and a fixed 12-h artificial light period.
(2) On day 15, the mice are fasted for 12 hours, anesthetized with pentobarbital sodium, and then all sacrificed.
(3) Collect mouse blood samples in 2mL EP tubes, centrifuge (3000rpm, 4°C, 10min), and then store at -80°C for biochemical determination.
(4) The kidney tissue is quickly removed, weighed and divided into two parts, one part was fixed in 4% paraformaldehyde for histopathological examination, and the other part is stored at -80°C for further biochemical determination.
Modeling Indicators
Molecular changes: Increased the levels of CRE, BUN, MDA, XOD and UA. Reduced the levels of SOD and GSH-Px in serum. Increased the levels of IL-1β and IL-18 in both serum and kidney and the mRNA expressions of IL-1β, NLRP3, ASC and caspase1.
Histological changes: Inconspicuous boundaries between adjacent proximal tubule cells, swelling and proximal tubule necrosis.
Correlated Product(s): Hypoxanthine (HY-N0091)
Opposite Product(s): Curcumin (HY-N0005)

OXONIC ACID POTASSIUM SALTSupplier

Jinan Sunshine Pharmaceutical Co.,Ltd. Gold
Tel
531-82812892
Email
sunshinepharm0531@163.com
Jinan Zhongke Yitong Chemical Co., Ltd. Gold
Tel
0531-88658009 15552873609
Email
lxxcs@163.com
Jinan Londi Medical Technology Co., LTD Gold
Tel
0531-88996911 15628983711
Email
3305202763@qq.com
Wuhan DKY Technology Co.,Ltd. Gold
Tel
027-81302411 15377658509
Email
zs@dkybpc.com
Shandong Chenxi Pharmaceutical Co., Ltd. Gold
Tel
+86-0531-88803416 13153166250
Email
sales@chemedpharma.com